[Translation] An international multicenter, randomized, double-blind, pivotal registration phase III study of APG-2575 (lisaftoclax) combined with azacitidine in the treatment of elderly patients with newly diagnosed acute myeloid leukemia
评估APG-2575 (Lisaftoclax)联合阿扎胞苷 (AZA)对比安慰剂联合阿扎胞苷在新诊断急性髓性白血病(AML)患者中的疗效。
[Translation] To evaluate the efficacy of APG-2575 (lisaftoclax) plus azacitidine (AZA) versus placebo plus azacitidine in patients with newly diagnosed acute myeloid leukemia (AML).